Hoerbiger Holding AG:企業の戦略的SWOT分析

◆英語タイトル:Hoerbiger Holding AG - Strategic SWOT Analysis Review
◆商品コード:SWOT20MY2300
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:Industrial Goods and Machinery
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Hoerbiger Holding AG – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Hoerbiger Holding AG (Hoerbiger) is a provider of industrial engineering solutions. The company’s product portfolio includes components for reciprocating compressors, gas engines, turbomachinery, rotary compressors, industrial explosion protection systems, industrial machinery, valve automation, hydraulic drives, mobile hydraulics and stationary hydraulic systems. It offers piezo technology solutions for vehicles and machine tools, and components and systems for shift and clutch operations in vehicle drive trains; and offers products and solutions in the fields of compression, automation and drive technologies for diverse industries including gas and process, machinery and plant construction, ship building and automotive. The company provides services such as reconditioning and repair, upgrading, equipment efficiency improvement, spare part agreements, and fault analysis. It operates in the Americas, Europe, the Middle East and Asia-Pacific. Hoerbiger is headquartered in Zug, Switzerland.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
Section 1 – About the Company
Hoerbiger Holding AG – Key Facts
Hoerbiger Holding AG – Key Employees
Hoerbiger Holding AG – Major Products and Services
Hoerbiger Holding AG – History
Hoerbiger Holding AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Hoerbiger Holding AG – Business Description
Business Segment: Compression Technology SBU
Overview
Performance
Business Segment: Drive Technology SBU
Overview
Performance
Business Segment: Engine
Overview
Performance
Business Segment: Hydraulics
Overview
Performance
Business Segment: Safety
Overview
Performance
R&D Overview
Hoerbiger Holding AG – SWOT Analysis
SWOT Analysis – Overview
Hoerbiger Holding AG – Strengths
Hoerbiger Holding AG – Weaknesses
Hoerbiger Holding AG – Opportunities
Hoerbiger Holding AG – Threats
Hoerbiger Holding AG – Key Competitors
Section 3 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Hoerbiger Holding AG, Key Facts
Hoerbiger Holding AG, Key Employees
Hoerbiger Holding AG, Major Products and Services
Hoerbiger Holding AG, History
Hoerbiger Holding AG, Subsidiaries
Hoerbiger Holding AG, Key Competitors

★海外企業調査レポート[Hoerbiger Holding AG:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Recipharm AB:企業のM&A・事業提携・投資動向
    Recipharm AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Recipharm AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Sapience Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sapience Therapeutics Inc (Sapience) is a preclinical-stage biotechnology company that focuses on developing novel therapeutics for major unmet medical needs with special emphasis on high mortality cancers. The company offers peptides that act at the level of transcriptional regulation of on …
  • Taiwan Liposome Co Ltd (4152):企業の財務・戦略的SWOT分析
    Summary Taiwan Liposome Co Ltd (TLC) is a clinical-stage pharmaceutical company, which develops and commercializes novel nanomedicines based on drug delivery technology platform. The company’s pipeline products include TLC599, TLC590, TLC399 and TLC178. Its TLC 178 is used for the treatment of adult …
  • Kuwait Food Company (Americana) K.S.C.P. (FOOD):企業の財務・戦略的SWOT分析
    Kuwait Food Company (Americana) K.S.C.P. (FOOD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • MISC Bhd (MISC):企業の財務・戦略的SWOT分析
    MISC Bhd (MISC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Denator AB:医療機器:M&Aディール及び事業提携情報
    Summary Denator AB (Denator) is a provider of heat stabilization technology solutions that markets, develops, and sells instruments and consumables to address needs in the life science and clinical research markets. The company provides products such as stabilizor peptide extraction kits, stabilizor …
  • Celdara Medical LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Celdara Medical LLC (Celdara Medical) is a biotechnology company that helps transform academic innovations into medicines to cure serious diseases. It provides pipeline development services, and has a pipeline of anti-inflammatory therapeutics, latent HIV elimination, idiopathic pulmonary fi …
  • RhythmOne plc:企業のM&A・事業提携・投資動向
    RhythmOne plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RhythmOne plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Kelly Services, Inc.:企業の戦略・SWOT・財務分析
    Kelly Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kelly Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Mississippi Power Co-エネルギー分野:企業M&A・提携分析
    Summary Mississippi Power Company (Mississippi Power), a subsidiary of Southern Company, is a vertically integrated electric utility which generates, procures, transmits, distributes, and sells energy. It produces power from coal and natural gas sources. Mississippi Power owns and operates fossil st …
  • Thai Airways International Public Co Ltd:企業の戦略・SWOT・財務情報
    Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Eidgenossische Technische Hochschule Zurich:製薬・医療:M&Aディール及び事業提携情報
    Summary Eidgenossische Technische Hochschule Zurich (ETH Zurich) is an educational service provider that offers studies in technology and the natural sciences. The university offers scientific education through bachelor programmes and master programmes in the areas of applied geophysics, architectur …
  • Shenzhen Jinjia Group Co., Ltd.:企業の戦略・SWOT・財務情報
    Shenzhen Jinjia Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shenzhen Jinjia Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Parkson Retail Group Limited:戦略・SWOT・企業財務分析
    Parkson Retail Group Limited - Strategy, SWOT and Corporate Finance Report Summary Parkson Retail Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • S Chand And Company Limited (SCHAND):企業の財務・戦略的SWOT分析
    S Chand And Company Limited (SCHAND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • PIQUR Therapeutics AG-製薬・医療分野:企業M&A・提携分析
    Summary PIQUR Therapeutics AG (PIQUR) is a clinical-stage pharmaceutical company that discovers and develops anti-cancer drugs. The company develops innovative small molecule therapeutics based on lipid kinase (PI3K) and mTOR inhibitior for the treatment of cancer and inflammatory diseases. Its pipe …
  • Tenaska Inc:発電所・企業SWOT分析
    Tenaska Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • I Grandi Viaggi Spa
    I Grandi Viaggi Spa - Strategy, SWOT and Corporate Finance Report Summary I Grandi Viaggi Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Chugai Pharmaceutical Co Ltd (4519)-製薬・医療分野:企業M&A・提携分析
    Summary Chugai Pharmaceutical Co Ltd (Chugai), a subsidiary of Hoffmann-La Roche Ltd, is a provider of biopharmaceuticals and therapeutic antibodies. The company offers products for the treatment of cancer; bone and joint diseases; renal diseases; immunology and infectious diseases and others. It al …
  • SK Biopharmaceuticals Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary SK Biopharmaceuticals Co Ltd (SK Biopharmaceuticals), a subsidiary of SK Holdings Co Ltd is a researcher and developer of drugs. The company develops and markets drugs for the treatment of central nervous system. It provides plumiaz, SKL-N05 and JZP-110; YKP3089, relenopride, SKL-PD, SKL-A4R …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆